Apelin/APJ system: a new target of atherosclerosis
Author:
Affiliation:

1.Institute of Pharmacy and Pharmacology, Hunan Province Cooperative Innovation Center for Molecular Target New Drug Study, University of South China, Hengyang, Hunan 421001, China;2.Department of Pharmacy, the First People's Hospital of Yueyang, Yueyang, Hunan 414000, China)

Clc Number:

R5

  • Article
  • | |
  • Metrics
  • |
  • Reference [51]
  • | | | |
  • Comments
    Abstract:

    Atherosclerotic diseases have become the leading cause of human death. Apelin/APJ receptors is widely found in the cardiovascular system, and is involved in the occurrence and development of a variety of cardiovascular diseases. Studies on the effects of Apelin/APJ system on atherosclerosis suggested that Apelin has dual effects on atherosclerosis. On the one hand, Apelin can promote the proliferation and migration of vascular smooth muscle cells and endothelial cells, and induce mononuclear cell adhesion to endothelial cells, which could promote angiogenesis, and affect the stability of As plaques. On the other hand, Apelin can antagoninize AngⅡ to regulate intracellular lipid metabolism, and reduce the generation of endothelial reactive oxygen species and cellular aging, prevent macrophages from turning into foam cells, and have a certain stabilizing effect on the As plaque that has been formed. In addition, it can also inhibit platelet activation, ultimately reducing the occurrence of atherosclerosis complications. Meanwhile, as a double-edged sword with protection or damage, autophagy may be one of the important targets of Apelin in atherosclerosis. This paper summarizes the research on Apelin/APJ system and atherosclerosis in the above aspects, and explores the possibility of Apelin/APJ receptor as a target for preventing or treating atherosclerosis.

    Reference
    [1] 刘亚密, 曾召林, 陈姣姣, 等.microRNA调节细胞自噬影响动脉粥样硬化.中国动脉硬化杂志, 8,6(12):1278-1284.
    [2] O'Dowd BF, Heiber M, Chan A, et al.A human gene that shows identity with the gene encoding the angiotensin receptor is located on chromosome 11.Gene, 3,6(1-2):355-360.
    [3] Tatemoto K, Hosoya M, Habata Y, et al.Isolation and characterization of a novel endogenous peptide ligand for the human APJ receptor.Biochem Biophys Res Commun, 8,1(2):471-476.
    [4] Kawamata Y, Habata Y, Fukusumi S, et al.Molecular properties of apelin:tissue distribution and receptor binding.Biochim Biophys Acta, 1,8(2-3):162-171.
    [5] Pitkin SL, Maguire JJ, Bonner TI, et al.International union of basic and clinical pharmacology.LXXIV.apelin receptor nomenclature, distribution, pharmacology, and function.Pharmacol Rev, 0,2(3):331-342.
    [6] Liu M, Li H, Zhou Q, et al.ROS-autophagy pathway mediates monocytes-human umbilical vein endothelial cells adhesion induced by apelin-13.J Cell Physiol, 8,3(10):6839-6850.
    [7] Lv D, Li H, Chen L.Apelin and APJ, a novel critical factor and therapeutic target for atherosclerosis.Acta Biochim Biophys Sin (Shanghai), 3,5(7):527-533.
    [8] 曹建刚, 李兰芳, 陈临溪.Apelin/APJ:血管功能调节因子和药物治疗新靶点.生物化学与生物物理进展, 5,2(8):721-732.
    [9] Chun HJ, Ali ZA, Kojima Y, et al.Apelin signaling antagonizes Ang Ⅱ effects in mouse models of atherosclerosis.J Clin Invest, 8,8(10):3343-3354.
    [10] Rittig K, Hildebrandt U, Thamer C, et al.Apelin serum levels are not associated with early atherosclerosis or fat distribution in young subjects with increased risk for type 2 diabetes.Exp Clin Endocrinol Diabetes, 1,9(6):358-361.
    [11] 唐荣, 王睿苓, 敖翔, 等.维持性血液透析患者血浆apelin水平与颈动脉粥样硬化的关系.中南大学学报(医学版), 7,2(6):617-622.
    [12] Dogan I, Dogan T, Yetim M, et al.Relation of serum ADMA, apelin-13 and LOX-1 levels with inflammatory and echocardiographic parameters in hemodialysis patients.Ther Apher Dial, 8,2(2):109-117.
    [13] Karbek B, Bozkurt NC, Topaloglu O, et al.Relationship of vaspin and apelin levels with insulin resistance and atherosclerosis in metabolic syndrome.Minerva Endocrinol, 4,9(2):99-105.
    [14] Sabry RN, El-Wakeel MA, El-Kassas GM, et al.Serum apelin:a new marker of early atherosclerosis in children with type 1 diabetes mellitus.Open Access Maced J Med Sci, 8,6(4):613-617.
    [15] Hashimoto T, Kihara M, Imai N, et al.Requirement of apelin-apelin receptor system for oxidative stress-linked atherosclerosis.Am J Pathol, 7,1(5):1705-1712.
    [16] Luo X, Liu J, Zhou H, et al.Apelin/APJ system:A critical regulator of vascular smooth muscle cell.J Cell Physiol, 8,3(7):5180-5188.
    [17] He L, Zhou Q, Huang Z, et al.PINK1/Parkin-mediated mitophagy promotes apelin-13-induced vascular smooth muscle cell proliferation by AMP Kalpha and exacerbates atherosclerotic lesions.J Cell Physiol, 9,4(6):8668-8682.
    [18] Eyries M, Siegfried G, Ciumas M, et al.Hypoxia-induced apelin expression regulates endothelial cell proliferation and regenerative angiogenesis.Circ Res, 8,3(4):432-440.
    [19] Zhang H, Gong Y, Wang Z, et al.Apelin inhibits the proliferation and migration of rat PASMCs via the activation of PI3K/Akt/mTOR signal and the inhibition of autophagy under hypoxia.J Cell Mol Med, 4,8(3):542-553.
    [20] Rudijanto A.The role of vascular smooth muscle cells on the pathogenesis of atherosclerosis.Acta Med Indones, 7,9(2):86-93.
    [21] Liu QF, Yu HW, You L, et al.Apelin-13-induced proliferation and migration induced of rat vascular smooth muscle cells is mediated by the upregulation of Egr-1.Biochem Biophys Res Commun, 3,9(2):235-240.
    [22] Wang C, Wen J, Zhou Y, et al.Apelin induces vascular smooth muscle cells migration via a PI3K/Akt/FoxO3a/MMP-2 pathway.Int J Biochem Cell Biol, 5,9:173-182.
    [23] Li X, Zhang X, Li F, et al.14-3-3 mediates apelin-13-induced enhancement of adhesion of monocytes to human umbilical vein endothelial cells.Acta Biochim Biophys Sin (Shanghai), 0,2(6):403-409.
    [24] Lu Y, Zhu X, Liang GX, et al.Apelin-APJ induces ICAM-1, VCAM-1 and MCP-1 expression via NF-kappaB/JNK signal pathway in human umbilical vein endothelial cells.Amino Acids, 2,3(5):2125-2136.
    [25] Berta J, Hoda MA, Laszlo V, et al.Apelin promotes lymphangiogenesis and lymph node metastasis.Oncotarget, 4,5(12):4426-4437.
    [26] Kwon HB, Wang S, Helker CS, et al.In vivo modulation of endothelial polarization by Apelin receptor signalling.Nat Commun, 6,7:11805.
    [27] Strohbach A, Pennewitz M, Glaubitz M, et al.The apelin receptor influences biomechanical and morphological properties of endothelial cells.J Cell Physiol, 8,3(8):6250-6261.
    [28] Jin HY, Chen LJ, Zhang ZZ, et al.Deletion of angiotensin-converting enzyme 2 exacerbates renal inflammation and injury in apolipoprotein E-deficient mice through modulation of the nephrin and TNF-alpha-TNFRSF1A signaling.J Transl Med, 5,3:255.
    [29] Loot AE, Schreiber JG, Fisslthaler B, et al.Angiotensin Ⅱ impairs endothelial function via tyrosine phosphorylation of the endothelial nitric oxide synthase.J Exp Med, 9,6(13):2889-2896.
    [30] Siddiquee K, Hampton J, McAnally D, et al.The apelin receptor inhibits the angiotensin Ⅱ type 1 receptor via allosteric trans-inhibition.Br J Pharmacol, 3,8(5):1104-1117.
    [31] Virdis A, Ghiadoni L, Giannarelli C, et al.Endothelial dysfunction and vascular disease in later life.Maturitas, 0,7(1):20-24.
    [32] Yang R, Fang W, Liang J, et al.Apelin/APJ axis improves angiotensin Ⅱ-induced endothelial cell senescence through AMPK/SIRT1 signaling pathway.Arch Med Sci, 8,4(4):725-734.
    [33] Izgut-Uysal VN, Gemici B, Birsen I, et al.The effect of apelin on the functions of peritoneal macrophages.Physiol Res, 7,6(3):489-496.
    [34] Zhang X, Ye Q, Gong D, et al.Apelin-13 inhibits lipoprotein lipase expression via the APJ/PKCalpha/miR-361-5p signaling pathway in THP-1 macrophage-derived foam cells.Acta Biochim Biophys Sin (Shanghai), 7,9(6):530-540.
    [35] Zhou X, Yin Z, Guo X, et al.Inhibition of ERK1/2 and activation of liver X receptor synergistically induce macrophage ABCA1 expression and cholesterol efflux.J Biol Chem, 0,5(9):6316-6326.
    [36] Liu XY, Lu Q, Ouyang XP, et al.Apelin-13 increases expression of ATP-binding cassette transporter A1 via activating protein kinase C alpha signaling in THP-1 macrophage-derived foam cells.Atherosclerosis, 3,6(2):398-407.
    [37] Fraga-Silva RA, Seeman H, Montecucco F, et al.Apelin-13 treatment enhances the stability of atherosclerotic plaques.Eur J Clin Invest, 8,8(3).doi:10.1111/eci.12891.
    [38] Li M, Fang H, Hu J.Apelin13 ameliorates metabolic and cardiovascular disorders in a rat model of type 2 diabetes with a highfat diet.Mol Med Rep, 8,8(6):5784-5790.
    [39] 陈然, 江璞, 刘玲燕, 等.Apelin对改善小鼠低氧性肺动脉高压的作用及与调节脂质代谢的关系.中国应用生理学杂志, 7,3(6):493-496,567.
    [40] Bertrand C, Pradere JP, Geoffre N, et al.Chronic apelin treatment improves hepatic lipid metabolism in obese and insulin-resistant mice by an indirect mechanism.Endocrine, 8,0(1):112-121.
    [41] Yu XH, Tang ZB, Liu LJ, et al.Apelin and its receptor APJ in cardiovascular diseases.Clin Chim Acta, 4,8:1-8.
    [42] Adam F, Khatib AM, Lopez JJ, et al.Apelin:an antithrombotic factor that inhibits platelet function.Blood, 6,7(7):908-920.
    [43] Li L, Xu J, Chen L, et al.Apelin/APJ system:a novel promising therapy target for thrombotic diseases.Acta Biochim Biophys Sin (Shanghai), 6,8(6):589-591.
    [44] 肖凌, 李兰芳, 陈临溪.自噬对血管功能的影响及与相关疾病的关联研究进展.生物化学与生物物理进展, 3,0(12):1177-1185.
    [45] Yao F, Lv YC, Zhang M, et al.Apelin-13 impedes foam cell formation by activating Class Ⅲ PI3K/Beclin-1-mediated autophagic pathway.Biochem Biophys Res Commun, 5,6(4):637-643.
    [46] Mialet-Perez J, Vindis C.Autophagy in health and disease:focus on the cardiovascular system.Essays Biochem, 7,1(6):721-732.
    [47] Huang Z, He L, Chen Z, et al.Targeting drugs to APJ receptor:From signaling to pathophysiological effects.J Cell Physiol, 8,4(1):61-74.
    [48] Iturrioz X, Alvear-Perez R, De Mota N, et al.Identification and pharmacological properties of E339-3D6, the first nonpeptidic apelin receptor agonist.FASEB J, 0,4(5):1506-1517.
    [49] Cheng J, Luo X, Huang Z, et al.Apelin/APJ system:a potential therapeutic target for endothelial dysfunction-related diseases.J Cell Physiol, 8,4(8):12149-12160.
    [50] Lee DK, Saldivia VR, Nguyen T, et al.Modification of the terminal residue of apelin-13 antagonizes its hypotensive action.Endocrinology, 5,6(1):231-236.
    [51] Macaluso NJ, Pitkin SL, Maguire JJ, et al.Discovery of a competitive apelin receptor (APJ) antagonist.Chem Med Chem, 1,6(6):1017-1023.
    Related
    Cited by
    Comments
    Comments
    分享到微博
    Submit
Get Citation

LI Hening, CHEN Linxi. Apelin/APJ system: a new target of atherosclerosis[J]. Editorial Office of Chinese Journal of Arteriosclerosis,2019,27(7):553-561.

Copy
Share
Article Metrics
  • Abstract:997
  • PDF: 893
  • HTML: 0
  • Cited by: 0
History
  • Received:March 10,2019
  • Revised:May 05,2019
  • Online: June 04,2019
Article QR Code